Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional aware study

HIGHLIGHTS

• who: Aaron Broadwell from the (UNIVERSITY) have published the paper: Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study, in the Journal: (JOURNAL)
• what: The primary reasons for study discontinuation included lack of effectiveness (27.1% for golimumab + MTX and 32.1% for golimumab without MTX) and AEs (9.3% for golimumab + MTX and 12.5% for golimumab without MTX). IV golimumab patients in this study had, on average, high disease activity and substantial prevalence of comorbidities, and thus may represent difficult . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.